HomeInsightsShare Holding

Aurobindo Pharma Ltd Share Holding Pattern

Aurobindo Pharma Ltd Share Holding Pattern

stocks purchased

₹ 1.4 Cr

Volume transacted

stocks purchased

9.4 K

stocks traded

Last Updated time: 19 Sep 9.00 AM

Promoters Holdings Over Time

Key Highlights

  • Mutual funds increased their stake in the company by 1.35% from March 2024 to June 2024.
  • Promoters decreased their stake in the company by 0.03% from March 2024 to June 2024. FIIs/FPIs decreased their stake in the company by 1.29% from March 2024 to June 2024.

Latest Shareholding

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Aurobindo Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
19 Sep 20241527.35
18 Sep 20241538.75
17 Sep 20241552.05
16 Sep 20241562.1
13 Sep 20241567.6
12 Sep 20241560.2
11 Sep 20241507.2
10 Sep 20241518.45
09 Sep 20241518.35
06 Sep 20241538.5

Aurobindo Pharma Ltd News Hub

News

Eugia Steriles receives concludes UFDA inspection of its new injectable facility

Aurobindo Pharma announced that the USFDA has issued the Establishment Inspection Report f...

Read more

18 Sep 202411:02

News

Auro Pharma arm gets EIR from USFDA for AP facility

The United States Food and Drug Administration (USFDA) had conducted a pre-approval inspec...

Read more

18 Sep 202412:07

News

Aurobindo Pharma arm gets USFDA nod for anesthetic drug

Lidocaine is a local anesthetic (numbing medication) that is used to numb an area of your ...

Read more

11 Sep 202412:26

News

Eugia Steriles receives its first product approval from USFDA for Lidocaine Hydrochloride Injection

Aurobindo Pharma announced that the new injectable facility of Eugia Steriles (a 100% subs...

Read more

11 Sep 202412:15

News

Aurobindo Pharma Ltd up for fifth session

Aurobindo Pharma Ltd is up for a fifth straight session in a row. The stock is quoting at ...

Read more

28 Aug 202413:00

News

Eugia Pharma Specialities receives USFDA warning for Unit III

Aurobindo Pharma announced that the USFDA has issued a warning letter for Unit-III of Eugi...

Read more

16 Aug 202410:06

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

June 2023

TranscriptPPT

June 2022

TranscriptPPT

Aug 2021

PPT

June 2021

TranscriptPPT

June 2020

TranscriptPPT

Jan 2020

PPT

FAQs for EPS of Aurobindo Pharma Ltd

On what factors does the shareholding pattern of Aurobindo Pharma Ltd change frequently?

The shareholding pattern of Aurobindo Pharma Ltd can change due to various factors such as stock market transactions, new share issuances, buy-backs, or changes in ownership by institutional and retail investors.

How often is Aurobindo Pharma Ltd's shareholding pattern updated?

The Aurobindo Pharma Ltd shareholding pattern is typically updated quarterly or semi-annually, depending on regulatory requirements and internal reporting schedules.

What categories are included in the shareholding pattern of Aurobindo Pharma Ltd?

Categories included in the shareholding pattern of Aurobindo Pharma Ltd include promoter/management holdings, institutional investors, retail investors, and others such as foreign investors.

Why is the shareholding pattern of Aurobindo Pharma Ltd important for investors?

The shareholding pattern of Aurobindo Pharma Ltd is important for investors as it provides insights into ownership distribution, control dynamics, and the potential influence of major shareholders on company decisions and stock performance.

Where can I find the latest shareholding pattern of Aurobindo Pharma Ltd?

The latest shareholding pattern of Aurobindo Pharma Ltd can be found on BlinkX. You may also check the quarterly financial reports, which are available on the company’s official website under the Investor Relations section. Additionally, you can check stock exchange websites like NSE and BSE for the most recent filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*